UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Population-Based Study of the Incidence and Complication Rates of Herpes Zoster Before Zoster Vaccine Introduction

Mayo Clinic proceedings, 2007-11, Vol.82 (11), p.1341-1349

2007

Volltextzugriff (PDF)

The Incidence of Herpes Zoster in a United States Administrative Database

Journal of general internal medicine : JGIM, 2005-08, Vol.20 (8), p.748-753

2005

Volltextzugriff (PDF)

Health Care Utilization and Cost Burden of Herpes Zoster in a Community Population

Mayo Clinic proceedings, 2009-09, Vol.84 (9), p.787-794

2009

Volltextzugriff (PDF)

Herpes Zoster Recurrences More Frequent Than Previously Reported

Mayo Clinic proceedings, 2011-02, Vol.86 (2), p.88-93

2011

Volltextzugriff (PDF)

Pneumococcal serotype distribution: A snapshot of recent data in pediatric and adult populations around the world

Human vaccines & immunotherapeutics, 2017-06, Vol.13 (6), p.1229-1241

2017

Volltextzugriff (PDF)

Safety of 4-valent human papillomavirus vaccine in males: a large observational post-marketing study

Human vaccines & immunotherapeutics, 2022-11, Vol.18 (5), p.2073750-2073750

2022

Volltextzugriff (PDF)

Long-Term Effectiveness of the Live Zoster Vaccine in Preventing Shingles: A Cohort Study

American journal of epidemiology, 2018-01, Vol.187 (1), p.161-169

2018

Volltextzugriff (PDF)

Safety of 9-valent human papillomavirus vaccine administered to males and females in routine use

Vaccine, 2023-03, Vol.41 (11), p.1819-1825

2023

Volltextzugriff (PDF)

Effectiveness of the live zoster vaccine during the 10 years following vaccination: real world cohort study using electronic health records

BMJ (Online), 2023-11, Vol.383, p.e076321

2023

Volltextzugriff (PDF)

Herpes zoster vaccine live: A 10 year review of post-marketing safety experience

Vaccine, 2017-12, Vol.35 (52), p.7231-7239

2017

Volltextzugriff (PDF)

Frequency of Herpes Zoster Recurrence–Reply–I

Mayo Clinic proceedings, 2011-06, Vol.86 (6), p.586-587

2011

Volltextzugriff (PDF)

Adaptation of a previously validated vaccination report card for use in adult vaccine clinical trials to align with the 2007 FDA Toxicity Grading Scale Guidance

Human vaccines & immunotherapeutics, 2012-09, Vol.8 (9), p.1208-1212

2012

Volltextzugriff (PDF)

Long-term effectiveness of zoster vaccine live for postherpetic neuralgia prevention

Vaccine, 2019-08, Vol.37 (36), p.5422-5427

2019

Volltextzugriff (PDF)

Vaccine initiation and 3-dose series completion of 4vHPV vaccine among US insured males 2012–2016

Vaccine, 2022-01, Vol.40 (4), p.682-688

2022

Volltextzugriff (PDF)

Incident autoimmune conditions among males receiving quadrivalent human papillomavirus vaccine in the United States

Vaccine, 2023-03, Vol.41 (11), p.1826-1833

2023

Volltextzugriff (PDF)

Long-term effectiveness of varicella vaccine: a 14-Year, prospective cohort study

Pediatrics (Evanston), 2013-05, Vol.131 (5), p.e1389-e1396

2013

Volltextzugriff (PDF)

Impact of vaccination on the epidemiology of varicella: 1995-2009

Pediatrics (Evanston), 2014-07, Vol.134 (1), p.24-30

2014

Volltextzugriff (PDF)

Safety of Zostavax™—A cohort study in a managed care organization

Vaccine, 2012-10, Vol.30 (47), p.6636-6641

2012

Volltextzugriff (PDF)

Vaccinations and the Risk of Relapse in Multiple Sclerosis

The New England journal of medicine, 2001-02, Vol.344 (5), p.319-326

2001

Volltextzugriff (PDF)

5. Observational Study of Routine Use of 9-Valent Human Papillomavirus Vaccine: Safe in More Than 140,000 Individuals

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S24-S25

2020

Volltextzugriff (PDF)

22. An Innovative Approach to Examining the Waning of Vaccine Effectiveness Using Automated Healthcare Data

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S135-S135

2021

Volltextzugriff (PDF)

Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting

Vaccine, 2009-07, Vol.27 (34), p.4656-4661

2009

Volltextzugriff (PDF)

The Impact of Acute Herpes Zoster Pain and Discomfort on Functional Status and Quality of Life in Older Adults

The Clinical journal of pain, 2007-07, Vol.23 (6), p.490-496

2007

Volltextzugriff (PDF)

Postherpetic neuralgia: epidemiology, pathophysiology and management

Expert review of neurotherapeutics, 2007-11, Vol.7 (11), p.1581-1595

2007

Volltextzugriff (PDF)

Herpes Zoster and Postherpetic Neuralgia: Optimizing Management in the Elderly Patient

Drugs & aging, 2008-01, Vol.25 (12), p.991-1006

2008

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(44)

Publikationsform

Sprache

Englisch
(49)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Population-Based Study of the Incidence and Complication Rates of Herpes Zoster Before Zoster Vaccine Introduction

The Incidence of Herpes Zoster in a United States Administrative Database

Health Care Utilization and Cost Burden of Herpes Zoster in a Community Population

Herpes Zoster Recurrences More Frequent Than Previously Reported

Pneumococcal serotype distribution: A snapshot of recent data in pediatric and adult populations around the world

Safety of 4-valent human papillomavirus vaccine in males: a large observational post-marketing study

Long-Term Effectiveness of the Live Zoster Vaccine in Preventing Shingles: A Cohort Study

Safety of 9-valent human papillomavirus vaccine administered to males and females in routine use

Effectiveness of the live zoster vaccine during the 10 years following vaccination: real world cohort study using electronic health records

Herpes zoster vaccine live: A 10 year review of post-marketing safety experience

Frequency of Herpes Zoster Recurrence–Reply–I

Adaptation of a previously validated vaccination report card for use in adult vaccine clinical trials to align with the 2007 FDA Toxicity Grading Scale Guidance

Long-term effectiveness of zoster vaccine live for postherpetic neuralgia prevention

Vaccine initiation and 3-dose series completion of 4vHPV vaccine among US insured males 2012–2016

Incident autoimmune conditions among males receiving quadrivalent human papillomavirus vaccine in the United States

Long-term effectiveness of varicella vaccine: a 14-Year, prospective cohort study

Impact of vaccination on the epidemiology of varicella: 1995-2009

Safety of Zostavax™—A cohort study in a managed care organization

Vaccinations and the Risk of Relapse in Multiple Sclerosis

5. Observational Study of Routine Use of 9-Valent Human Papillomavirus Vaccine: Safe in More Than 140,000 Individuals

22. An Innovative Approach to Examining the Waning of Vaccine Effectiveness Using Automated Healthcare Data

Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting

The Impact of Acute Herpes Zoster Pain and Discomfort on Functional Status and Quality of Life in Older Adults

Postherpetic neuralgia: epidemiology, pathophysiology and management

Herpes Zoster and Postherpetic Neuralgia: Optimizing Management in the Elderly Patient

Suchergebnisse filtern